Company Profile
Updated: 16-SEP-09Boehringer Ingelheim Animal
International Private company
Binger St. 173, Ingelheim Am Rhein, 55218, Germany
()6132770, 6132720 fax,
Primary SIC: In Vitro & In Vivo Diagnostic Agents, Primary NAICS: In-Vitro Diagnostic Substance Manufacturing
Description: Manufacturing: Diagnostic Substances
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
genOway acquires exclusive license for Flex technology developed by Professor Pierre Chambon and Dr. Norbert Ghyselinck at the IGBMC.
Blood Weekly; 11/19/2009; 1408 words; ...genetically modified animal models, reports the...even more predictive animal models. In fact, it...market this technology in animal models. We have already...industry (Pfizer, Bayer, Boehringer Ingelheim, etc.), and with...supplying laboratory animals), Invitrogen (NASDAQ...
Research on type 2 diabetes detailed by A. Tiwari and co-authors.
Diabetes Week; 11/16/2009; 1098 words; ...According to recent research from Bangalore, India, "Boehringer Ingelheim Corp is developing the novel, xanthine-based dipeptidyl...levels and improved glucose tolerance in both healthy animals and models of disease. Furthermore, linagliptin...
United States: Boehringer Ingelheim Deal With Pfizer Closes.
TendersInfo; 11/15/2009; 642 words; Byline: shiv03 Boehringer Ingelheim VetMedica Inc. has closed...portion of the Fort Dodge Animal Health Business. Boehringer Ingelheim, which has its American...increases the size of Boehringer Ingelheim's companion animal and...
Other News To Note.
BIOWORLD Today; 11/4/2009; 2862 words; ...scheduled to begin later this year in Europe. o Boehringer Ingelheim Pharmaceuticals Inc., of Ridgefield, Conn., reported...suppress angiogenesis and inhibit tumor growth in animal models of melanoma and breast cancer. The company...
MHRA's Report On TeGenero Trial: Mostly, Nothing Wrong.
BIOWORLD Today; 11/3/2009; 1035 words; ...TGN1412's manufacturer, Boehringer Ingelheim, the unnamed laboratory...carried out the pivotal animal toxicology studies of...unpredictable, and asked if the animals involved were an appropriate...TGN1412 had on the test animals. She also questioned...
Recent News Articles
- Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer.
PR Newswire - October 26, 2009 - German pharma major Boehringer Ingelheim and its US animal health business Boehringer Ingelheim Vetmedica has entered into an agreement with US pharma major Pfizer to acquire Wyeth Pharmaceutical's Fort Dodge Animal Health business on the closure of Pfizer's merger with Wyeth, which is expected in Q4 2009.(Companies, technology & environment)
Chemistry and Industry - October 12, 2009 - Pfizer and Wyeth to Sell Certain Animal Health Assets to Boehringer Ingelheim.
Wireless News - October 01, 2009 - Boehringer Ingelheim (BI) enters into an agreement with Pfizer to acquire certain assets of Wyeth Pharmaceuticals' Fort Dodge Animal Health business upon the closing of the global Pfizer-Wyeth merger.(AT CLOSING NEWS)
Agri Marketing - October 01, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning